Page 21 - ஆய்வகங்கள் கண்புரை அறுவை சிகிச்சை சாதனங்கள் விற்பனை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஆய்வகங்கள் கண்புரை அறுவை சிகிச்சை சாதனங்கள் விற்பனை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஆய்வகங்கள் கண்புரை அறுவை சிகிச்சை சாதனங்கள் விற்பனை Today - Breaking & Trending Today

How to Achieve Better Titration Reproducibility and Compliance with GxP

Many laboratories are still using manual titration to perform their routine analysis. Click to read more. ....

Worldwide Respiratory Disease Testing Industry to 2026 - by Type, Application, End-user and Country


Worldwide Respiratory Disease Testing Industry to 2026 - by Type, Application, End-user and Country
February 17, 2021 07:08 ET
| Source:
Research and Markets
Research and Markets
Dublin, IRELAND
ResearchAndMarkets.com s offering.
The study predicts the short term and long term trends that can shape the future of the Respiratory Disease Testing market including the COVID-19 pandemic implications for the Respiratory Disease Testings industry. The report presents market size forecasts across types, applications, end users and countries across regions. Strategic imperatives for development managers, decision makers and industry professionals including market trends, drivers, challenges, five forces analysis, insights on markets and companies.
The Respiratory Disease Testing market forecast report identifies growth opportunities in the market and how companies are reacting to the current market condition ....

Research And Markets , Clinical Laboratories , Clinical Laboratory , In Vitro Diagnostics , Respiratory Disease Testing , ஆராய்ச்சி மற்றும் சந்தைகள் , மருத்துவ ஆய்வகங்கள் , மருத்துவ ஆய்வகம் , இல் விட்ரோ பரிசோதனை , சர்வதேச பரவல் , சுவாச நோய் சோதனை ,

Perk Labs Inc.: Perk Labs Announces At-the-Market Equity Program Renewal


Perk Labs Inc.: Perk Labs Announces At-the-Market Equity Program Renewal
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
VANCOUVER, BC / ACCESSWIRE / February 17, 2021 / Perk Labs Inc. (CSE:PERK) ( Perk Labs or the Company ), the owner of Perk Hero, the all-in-one mobile ordering, contact-free payments and loyalty app, today announced that it has established an At-The-Market Equity Program (the ATM Program ) that allows the Company to periodically issue and sell up to C$4,000,000 worth of common shares in the capital of the Company (the Common Shares ) from treasury to the public, at the Company s discretion. All Common Shares sold under the ATM Program will be sold through the Canadian Securities Exchange or another Canadian marketplace (as defined in National Instrument 21-101 - ....

United States , South Australia , British Columbia , Iryna Zheliasko , Jonathan Hoyles , National Instrument , Borden Ladner Gervais , Company The Common , Market Equity Program , Corporate Communications , Canadian Securities Exchange , Labs Inc , Echelon Wealth Partners Inc , Perk Labs , Perk Hero , At The Market Equity Program , Common Shares , Echelon Wealth Partners , Perk Hero App , Prospectus Supplement , Shelf Prospectus , Electronic Document Analysis , ஒன்றுபட்டது மாநிலங்களில் , தெற்கு ஆஸ்திரேலியா , பிரிட்டிஷ் கொலம்பியா , தேசிய கருவி ,